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Abstract. Optimal interpretation of the results of intraoperative parathy-
roid hormone (IOPTH) monitoring during neck exploration for primary
hyperparathyroidism (pHPT) is still controversial. The reliability of the
“50% rule” in multiglandular disease (MGD) is often disputed, mostly be-
cause of competing pathophysiologic paradigms. The aim of this study was
to ascertain and corroborate the ability of IOPTH monitoring to detect
MGD in a practice, combining conventional and alternative parathyroid-
ectomy techniques. This is a retrospective single institution analysis of 69
consecutive patients undergoing cervical exploration for pHPT by various
approaches. The IOPTH measurements were performed after induction of
anesthesia but prior to skin incision and 10 minutes after excision of the
first visualized enlarged parathyroid gland. In this series, 55 patients
(80%) had single adenomas, and 14 patients (20%) had MGD. In 8 of the 14
patients with MGD, IOPTH levels were obtained sequentially after removal
of every enlarged gland. Of these 8 patients, 6 (75%) had a false-positive
decrease (decrease below 50% of baseline value in presence of another en-
larged gland) failing to predict the presence of a second enlarged gland. In
2 cases IOPTH monitoring provided a true-negative result, correctly pre-
dicting MGD. If MGD is defined by gross morphologic criteria, IOPTH
monitoring fails to predict the presence of MGD reliably. However, if MGD
is defined by functional criteria, the course of these patients does not seem
significantly affected. The importance of these findings must be further
investigated, especially with regard to the outcome of minimally invasive
parathyroid procedures.
Since its introduction, intraoperative parathyroid hormone
(IOPTH) monitoring has become a common adjunct to initial and
reoperative surgery for primary hyperparathyroidism (pHPT) in
most institutions with a large experience in endocrine surgery, es-
pecially if a minimal invasive approach is employed [1–3]. A de-
crease of more than 50% by 10 minutes in relation to the preopera-
tive baseline value with a return to normal range after resection of
the hyperfunctional parathyroid glands is now considered to be
predictive of either postoperative biochemical cure or normocalce-
mia [2, 4, 5].
Traditionally the operation for pHPT has consisted of a bilateral
neck exploration to identify all parathyroid glands. The extent of
the resection was determined by the gross macroscopic changes in
size, color, and consistency of the glands. IOPTH monitoring is use-
ful to assess the adequacy of resection by functional means without
the need to expose all the parathyroid glands. This can result in a
reduction of operating time and costs [6]. Based on the accuracy of
IOPTH monitoring and improved localization studies, especially
technetium 99m sestamibi scintigraphy, several different limited
access or minimally invasive techniques to excise a visualized para-
thyroid adenoma have since been developed [7–11].
However, there are still some concerns among endocrine sur-
geons about the benefits, the interpretation, and the applicability of
the results of IOPTH measurements to specific clinical situations
[12–14]. One of the concerns relates to the ability of IOPTH-
monitoring to detect multiglandular disease (MGD) [14–16]. The
frequency of MGD defined by macroscopic criteria varies from
11% to 26% [17–19]. However, the incidence of MGD was only 5%
if MGD was determined to some degree by parathyroid hormone
production [20].
The use of targeted operative approaches obviously does not al-
low the inspection of all parathyroid glands. Because an IOPTH fall
of more than 50% justifies a limited inspection and therefore an
abbreviated operation in relation to the conventional bilateral ex-
ploration, it can be assumed that in a substantial percentage of
cases enlarged glands would be left in situ. These remaining en-
larged glands might eventually hyperfunction at a later stage and
therefore may have a detrimental effect on the medium-term and
long-term success rate.
Recent publications indicate that there are in fact such false-
positive IOPTH monitoring results in MGD that fail to predict the
presence of an additional pathologically enlarged gland [5, 14, 16,
21].
The goals of the present study were (1) to determine the fre-
quency of false-positive and true-negative IOPTH monitoring re-
sults in the setting of pHPT with MGD and (2) to assess whether,
with targeted approaches, the rate of persistent pHPT from a pos-
sible remaining enlarged gland is the same as with a conventional
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This is a retrospective single institutional study off 69 consecutive
patients (56 women [81%], 13 men [19%], median age 67 years,
[range: 33–87]) with pHPT who underwent conventional bilateral
parathyroid exploration or videoendoscopic parathyroidectomy
with IOPTH monitoring at the surgical department of the Kan-
tonsspital St. Gallen, Switzerland, from September 1999 to Decem-
ber 2002. All patients had well-documented biochemical evidence
of pHPT. To ascertain cure of pHPT after surgery, patients were
clinically and biochemically followed after hospital discharge at 6
weeks and 6 months postoperatively. Patients with MEN-
associated pHPT, familial pHPT, or lithium-induced HPT were ex-
cluded from the study because of the different underlying patho-
genesis and the different surgical approach (n = 11).
Preoperative Localization Studies
Every patient underwent a preoperative cervical ultrasound. If a
mass consistent with a parathyroid adenoma could be localized
sonographically and there was no evidence of relevant thyroid pa-
thology, a technetium 99m sestamibi scintigraphy scan was per-
formed. In case of corresponding findings in both investigations, a
targeted videoendoscopic exploration was performed.
Operations
A total of 71 operations were performed on 69 patients. Two dif-
ferent surgical interventions were applied for primary explorations
(n = 67): conventional operation (n = 47) consisted always of a
standard bilateral neck exploration with the goal of inspecting all
parathyroid glands. In selected patients (n = 20), a targeted video-
endoscopic IOPTH-controlled approach to previously localized
adenomas by imaging studies was performed.
Four operations were done in patients with persistent or recur-
rent pHPT. In three of these cases the pathological gland was found
by cervical reexploration. In one patient a mediastinal adenoma
was removed via the thoracoscopic approach.
In 25 patients partial or total thyroidectomy was added for the
management of a relevant pathology of the thyroid gland (uninodu-
lar or multinodular goiter in 21, well-differentiated thyroid carci-
noma in 4). All parathyroidectomies were performed by the same
attending surgeon.
IOPTH
The IOPTH was measured in a peripheral blood sample of all pa-
tients after induction of anesthesia but prior to skin incision (Time0
or T0) and 10 minutes after excision of the first pathologically en-
larged gland or by the end of the procedure if multiple glands were
excised (Time1 or T1). At the beginning of our experience with
IOPTH monitoring, the first measurement in recognized MGD
was taken after all enlarged glands were excised. This strategy was
initially chosen to minimize the number of measurements and to
save costs. After the first encounter with a false-positive IOPTH
result in MGD, PTH was measured sequentially 10 minutes after
resection of each enlarged gland.
The measurements of intact PTH were performed with the IM-
MULITE Turbo Intact PTH Immunoassay (Diagnostic Products
Corporation, Los Angeles, CA, USA). The predictive value of
IOPTH monitoring was investigated in regard to the presence of an
additional enlarged gland based on gross morphological criteria or
with respect to cure, determined by normocalcemia at 6 months
postoperatively. Results with a decrease in PTH levels of more than
50% from the baseline value at 10 minutes and evidence of just one
pathological parathyroid gland in a bilateral neck exploration were
considered to be true-positives in terms of the gross macroscopic
findings (TPgross). If IOPTH monitoring correctly predicted cure,
the term TPcure is applicable as well. The term false-positive
(FPgross) is used in the situation of a decrease of more than 50% in
IOPTH monitoring in the presence of at least one additional en-
larged parathyroid gland. A decrease in PTH of less than 50% in
the presence of one or more enlarged glands is consistent with a
true-negative (TNgross) result.
Statistics
Statistical analyses were performed using SAS Version 8.2 (SAS
institute Inc., Cary, NC, USA). Data were presented as median and
range. The IOPTH values and the percentage of PTH decrease
were compared between the MGD group and the single adenoma
group and between the single adenoma group and the targeted re-
section group using the Wilcoxon rank-sum test. A p value < 0.05
was considered statistically significant.
Results
In this series, 55 patients (80%) were found to have one enlarged
parathyroid gland. Two patients had persistent pHPT after conven-
tional initial bilateral neck exploration with a missing inferior
gland. They underwent successful reoperation after an ectopic ad-
enoma was localized by imaging studies. One had cervical reex-
ploration, and the other underwent thoracoscopic operation to the
mediastinum.
A total of 14 patients (20%) were found to have MGD (double
adenoma 8, hyperplasia 6). All patients with MGD were explored
by a conventional bilateral operation and the pathology was estab-
lished by gross morphologic criteria. Follow-up examination for
these patients was accomplished at 6 weeks and 6 months after the
operation. All patients were biochemically cured as defined by nor-
mocalcemia at follow-up.
In the subsetting of double adenomas (n = 8) there were two
cases of true-negative test results (TNgross). In three patients we
observed a false-positive drop in the IOPTH levels in presence of a
second enlarged gland (FPgross) (Fig. 1). In the remaining three
patients PTH was measured only after both enlarged glands had
been removed. With regard to cure, the results in these three cases
were true-positive (TPcure).
In primary hyperplasia (n = 6) three patients had false-positive
results (FPgross). In the other three patients, PTH was measured
only after subtotal parathyroidectomy; that result was also found to
be a true-positive with regard to postoperative normocalcemia
(TPcure).
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Summing up the results in MGD (n = 14), we found six patients
with false-positive IOPTH results (FPgross) and two others with
true-negative IOPTH results (TNgross). In the remaining six pa-
tients with MGD, PTH was measured only after excision of the
whole pathology; the result regarding cure was true-positive in all
six cases (TPcure). The IOPTH findings after excision of all en-
larged glands in the patients with FPgross—and TNgross—results af-
ter excision of the first gland were also true-positive in terms of cure
(TPcure).
Overall, PTH levels were sequentially measured after excision of
every enlarged gland in eight patients with MGD. In this subgroup,
six patients (75%) had a FPgross result; the other two (25%) had
true-negative IOPTH results (TNgross). The ability of IOPTH
monitoring to rule out an additional enlarged gland (specificity) in
this setting of patients with MGD was therefore 25%.
The median decrease of PTH levels at T1 in the MGD group with
false-positive IOPTH results (FPgross) was 67.8% (Table 1 (Fig. 2).
The median decrease of PTH levels at T1 in patients with a single
adenoma, conventional bilateral operations, and true-positive de-
creases (TPgross) was 84% and was significantly higher compared to
the MGD group with FPgross results (p value = 0.006).
The median decrease of PTH levels at T1 in patients who under-
went targeted videoendoscopic (n = 20) resection of an adenoma
and who had true-positive IOPTH result regarding cure (TPcure)
was 85.8%, very similar to the result in patients with a single ade-
noma and conventional bilateral operations (p value > 0.5). All
patients with a targeted approach were cured as defined by normo-
calcemia at follow-up (median 6 months; range: 1.5to 13 months).
In all three patients with double adenomas and a false-positive
IOPTH result the second excised adenomas were considerably
smaller than the first ones (Table 2). The median weight of the first
one was 550 mg as compared with the median weight of the second
one at 158 mg. In the two cases with a double adenoma constella-
tion and a true-negative decrease in the PTH level, the weights of
the first adenomas were significantly greater, with weights of 11g
and 1.5g.
Discussion
Not since its introduction by F. Mandl [22], has parathyroid surgery
been subjected to as much innovation and controversy as it has
since the introduction of IOPTH monitoring a few years ago. We
investigated the data of consecutive patients undergoing standard
of targeted parathyroidectomies at our institution to address the
value of IOPTH monitoring in MGD and its implications for a hy-
brid practice of targeted and standard parathyroidectomy tech-
niques.
Our data have shown that using IOPTH monitoring with a cutoff
threshold of 50% at 10 minutes after excision of the first visualized
enlarged parathyroid gland failed to rule out multiglandular para-
thyroid enlargement in most of the cases where all glands could be
inspected. In only two of our eight patients, IOPTH monitoring
correctly indicated the presence of an additional pathologically en-
larged gland.
Because targeted approaches do not allow inspection of unre-
sected glands, it is very likely that enlarged glands remained in situ
in that subgroup of our operated patients. However, this has had no
apparent clinical consequence in the follow-up in regard to cure, as
defined by normocalcemia.
Also, because about 15% of patients with pHPT have MGD, and
a growing number of endocrine surgeons rely on IOPTH monitor-
ing in minimally invasive targeted procedures for pHPT, the value
of IOPTH monitoring as an adjunctive intraoperative tool needs to
be well defined.
Prior to the introduction of IOPTH measurement and targeted
operative approaches, the intraoperative assessment of parathy-
roid pathology relied upon the gross macroscopic findings. The im-
portance of a complete inspection of all parathyroid glands for a
successful operation was underscored from the very beginning of
parathyroid surgery by Mandl [23]. Edis et al. showed in 1977 that
cure rates above 95% with minimal morbidity could be achieved by
excising the macroscopically enlarged parathyroid glands only [24].
For many years, the standard operation for pHPT has been a bilat-
eral neck exploration exposing all four glands and removing the
gross macroscopic pathology. This procedure has been enormously
successful, with well-documented cure-rates of about 95% in the
hands of experienced endocrine surgeons.
If we assume that the removal of all enlarged parathyroid glands
is essential to cure, the fact that IOPTH monitoring fails to predict
the presence of residual enlarged glands would have relevance for
the cure rate. Therefore the success of the operation would be at
risk if the surgeon did not expose all glands and relied only on the
IOPTH measurement to assess the extent of the necessary resec-
tion. Based on these considerations targeted operative techniques
done without demonstrating all glands would have a detectable fail-
ure rate. Because the standard for this operation is a cure rate of
approximately 95%, any procedure having a lower rate because of
a limited exploration and the inadequacy of IOPTH monitoring
would be at least questionable.
On the other hand, we can assume that about 15% of the patients
with pHPT have MGD defined by gross macroscopic criteria and
about 50% of the targeted explorations in patients with MGD have
residual enlarged parathyroid glands left in place based on false-
positive IOPTHresults. A decrease in the cure rate in patients with
limited explorations would thus be expected. In contrast to that
estimation, however, the published cure rates of authors using dif-
ferent minimally invasive techniques show barely any relevant fail-
ure rates at medium-term follow-up [6, 11, 25, 26] (Table 3). In fact,
the reported medium-term cure rates of these authors are as excel-
lent as the known results of conventional exploration in experi-
enced hands. Essentially, that would mean that the same results
could be achieved either by conventional exploration excising all
Fig. 1. Intraoperative parathyroid hormone results in patients with double
adenomas and consecutively measured parathyroid hormone levels after
excision of every enlarged gland.
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parathyroid pathology on gross findings or by limited resection ac-
companied by a drop of more than 50% in the IOPTH monitoring.
This conclusion involves accepting the fact that there would remain
nonsecreting or hyposecreting enlarged parathyroid glands in some
patients. The behavior of these remaining enlarged glands is crucial
to the long-term success of targeted parathyroidectomy. If a non-
secreting adenoma could start autonomous PTH production
weeks, months, or years after the excision of the first predominantly
secreting adenoma, it would lead to a higher recurrence rate fol-
lowing targeted procedures. One such well-documented case has
recently been reported by Zettinig et al. [27]. A 47-year-old woman
had evidence of biochemical cure as defined by normocalcemia and
normal iPTH levels one week after a successful minimally invasive
open resection of enlarged gland in the left thyrothymic ligament.
Four weeks later the patient developed hypercalcemia, followed by
elevated levels of iPTH. After repeated localization studies, a sec-
ond adenoma with a diameter of 10 mm was removed from the right
thyrothymic ligament. The values for calcium and iPTH remained
normal during 12 months of follow-up.
A pathophysiologic explanation for different secreting patterns
of enlarged glands in a patient with MGD might be the hypothesis
of different “set points” for PTH secretion in each enlarged gland.
Brown et al. studied the effect of calcium concentrations on the
release of PTH in dispersed parathyroid cells [28]. They found a
heterogeneous responsiveness to calcium levels in different patho-
logic conditions. Cell cultures out of adenomas tended to have
more elevated and more variable set points (calcium concentration
half-maximally inhibiting PTH release) than parathyroid cells ex-
tracted from normal or hyperplastic parathyroid tissue. If after re-
section of the predominantly hypersecreting adenoma the calcium
level would stay above the set point of the remaining enlarged
gland, no excessive PTH production would occur, and therefore the
remaining enlarged gland would be missed by IOPTH monitoring
at the time of exploration. To achieve long-term results with tar-
geted parathyroidectomy equivalent to the results obtained with
standard bilateral exploration, it is crucial to know whether the set
point of an adenoma remaining in situ might change over time and
why it might do so.
The fact that the median IOPTH decrease 10 minutes after ex-
cising the first enlarged gland in the false-positive group (FPgross, n
= 6) was significantly less than in the true-positive group (TPgross, n
= 31) with a single adenoma is interesting and may be a hint that
there is an additional enlarged gland (Fig. 2). Investigating these
differences in respect to behavior—or rather kinetics—of IOPTH
in these two groups may offer a way to better differentiate the de-
crease pattern of both. It might then be possible to establish rules
that would be more accurate in predicting the presence of MGD
than the gross 50% rule.
In our data, double adenomas were associated with FPgross in
three of the five patients. These findings are similar to other data
published recently. In 1999 Gordon et al. reported four false-
positive results in 14 patients with double adenomas undergoing
bilateral exploration [5]. Gauger at al. analyzed the data of 457 pa-
tients who had undergone conventional parathyroidectomy at two
institutions [16]. Patients with limited exploration were excluded.
Twenty patients were reported to have double adenomas, corre-
sponding to 4.4% of the operated patients. Of those, 55% were
found to have false-positive results in IOPTH monitoring. Jaskow-
iak et al. investigated IOPTH results in 57 consecutive patients [14].
Most of the operations were done by bilateral exploration. In four
patients a double adenoma constellation was found. Two of the
four patients had false-positive IOPTH results, whereas the other
two had true-negative results. The cumulative experience with
double adenomas of these authors is summarized in Table 4. The











n 31 20 6
PTH at baseline 183 (65–2370) 148.5 (62–440) 212.5 (108–1025) NS NS
PTH at 10 minutes 28 (5–213) 21 (8–70) 68 (41–286) 0.01 NS
% decrease 84% 85.8% 67.8% 0.006 NS
MGD: multiglandular disease; TPgross: true-positive gross macroscopic findings; FPgross: false-positive gross macroscopic findings; TPcure: true-positive
cure; NS: p value > 0.05.
Fig. 2. Comparison of the median decrease at T1 of TPgross (true-positive
gross macroscopic findings; single adenoma and conventional exploration),
TPcure (true-positive cure; videoendoscopic exploration), and FPgross (false-
positive gross macroscopic findings; multiglandular disease). Gray bars:
baseline; black bars: T1.






False-positive (n = 3) 630 160
550 158
340 mg 110
True-negative (n = 2) 11,000 Not documented
1500 170
IOPTH: intraoperative parathyroid hormone.
190 World J. Surg. Vol. 28, No. 2, February 2004
specificity of IOPTH results in the combined experience for the
grossly defined double adenoma setting was merely 53.5% (speci-
ficity defined as true-negative results/(true-negative results +
false-positive results)).
Late parathyroid function after IOPTH guided parathyroidecto-
my has been studied by Carneiro and Irvin [29]. They compared the
medium-term results of successful parathyroidectomy guided by
IOPTH monitoring with the long-term results of successful stan-
dard bilateral neck exploration. In their study the secretory func-
tion of the remaining nonvisualized glands at 2 years after the
IOPTH guided operation was not significantly different from func-
tion in the patients who had undergone bilateral neck exploration
with excision of all grossly enlarged glands. However, patients with
persistent disease, defined as hypercalcemia and elevated iPTH
within 6 months, had been excluded to emphasize the long-term
results of both operative approaches. Therefore, patients with early
recurrences within the first half-year after the operation were not
included and may have created a bias.
Nevertheless, the mid-term results of IOPTH-guided targeted
parathyroidectomy published to date seem to indicate that the cure
rates are similar to those achieved with conventional bilateral neck
exploration [6, 11, 25, 26, 29]. If these results could be reproduced
in true longitudinal long-term studies, they would not only further
justify targeted parathyroidectomy with IOPTH monitoring, they
would also correspond to a change in assumptions about parathy-
roid pathophysiology. Such conclusions would also suggest that the
presence of a functional assessment of parathyroid normality has
truly supplanted the previous gross size assessment of pathology.
Conclusions
In our study, IOPTH monitoring failed to predict the presence of
residual grossly enlarged parathyroid glands in 75% of the cases, on
the basis of the threshold of a mandatory decrease of at least 50%
from the preoperative baseline PTH value at 10 minutes after ex-
cision of the first visualized enlarged gland. However, there is in-
creasing evidence that there may be different secreting pattern in
different parathyroid adenomas and that resection of the exclu-
sively hypersecreting adenoma or adenomas alone could lead to
cure. At this stage we may have reached a point where we must
reassess our comprehension of the pathophysiology of the parathy-
roid glands and therefore our approach to treatment.
Résumé. L’interprétation optimale peropératoire des résultats du dosage
de l’hormone parathyroı̈dienne (IOPTH) pendant l’exploration cervicale
pour hyperparathyroı̈die primitive (pHPT) reste un sujet de controverse.
La fiabilité de la règle des “50%” en ce qui concerne la maladie multiglandulaire
(MGD) est souvent mise en défaut par rapport aux paradigmes
physiopathologiques. Le but de cette étude a été de déterminer et de
corroborer la capacité du monitorage IOPTH pour détecter la MGD dans
une pratique qui combine les techniques de parathyroı̈dectomie
conventionnelle et mini-invasive. Par une analyse rétrospective mono
institutionnelle de 69 patients consécutifs ayant eu une exploration
cervicale pour pHPT par des approches différentes, on a mesuré l’IOPTH
après induction anesthésique mais avant l’incision cutanée et 10 minutes
après excision de la première glande parathyroı̈de augmentée de volume.
55 patients (80%) avaient un seul adénome et 14 patients (20%) avaient une
MGD. Chez huit des 14 patients MGD, les taux d’IOPTH ont été obtenus de
façon séquentielle après l’ablation de chaque glande augmentée de volume.
Six de ces huit patients (75%) avaient une diminution faussement positive
(diminution des valeurs de base inférieure à 50% en présence d’une autre
glande augmentée de volume) un échec dans la prédiction de la présence
d’une deuxième glande augmentée de volume. Dans deux cas, le monitorage
IOPTH a montré un résultat négatif vrai prédisant correctement la MGD.
Si la MGD est définie par des critères morphologiques macroscopiques, le
monitorage par l’IOPTH ne prédit pas fidèlement la présence de MGD.
Cependant, si la MGD est définie par des critères fonctionnels, l’évolution
de ces patients ne semble pas être affectée. L’importance de ces données
doit être explorée d’avantage surtout eu égard à l’évolution de la chirurgie
mini-invasive pour cette pathologie.
Resumen. La optima interpretación de los resultados de la monitoria
intraoperatoria de hormona paratiroidea (PTHIO) en el curso de una
exploración cervical por hiperparatiroidismo primario (HPTp) todavı́a es
motivo de controversia. La confiabilidad de la regla de “50%” en los casos
de enfermedad multiglandular (EMG) es frecuentemente disputada,
generalmente en relación con competentes paradigmas fisiopatológicos. El
propósito del presente estudio fue comprobar y corroborar la capacidad de
la monitorı́a de la PTHIO en la detección de EMG en una práctica que
combina técnicas de paratiroidectomı́a convencionales y alternativas. Es
un estudio retrospectivo realizado en una sola institución sobre 69
Table 3. Cure rates of targeted minimally invasive procedures for pHPT.
Authors Cases Procedure Follow-up (months) Cure rate
Prager et al. [11]; Zitinig et al. [27] and
Niederle, personal communication
5/20/02
103 Open minimal invasive parathroidectomy (oMIP) 6–22 98.1%
Henry et al. [25] 166 Video-assisted parathyroidectomy by lateral approach
(VAPLA)
3–33 100%
Lorenz. et al. [26] 123 Minimal invasive video-assisted parathyroidectomy
(MIVAP)
3–12 100%
Udelsman [6] 255 Minimally invasive Parathyroidectomy (MIP) Mean: 14 months 99%
pHPT: primary hyperparathyroidism.











Gordon et al. [5] 19.4% Bilateral 14 10 4
Gauger et al. [16] 4.4% Bilateral 20 9 11
Jaskowiak et al. [14] 7.0% Bilateral 4 2 2
Own experience 11.6% Bilateral 5 2 3
Combined results 43 23 (53.5%) 20 (46.5%)
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pacientes consecutivos sometidos a exploración cervical por HPTp por
abordajes diversos. Las mediciones de PTHIO fueron realizadas luego de
la inducción de la anestesia pero antes de la incisión de la piel y a los 10
minutos después de la resección de la primera glándula que aparecı́a
aumentada de tamaño. 55 pacientes (80%) tuvieron adenomas únicos y 14
20%) EMG. En 8 de los 14 pacientes con EMG, los niveles de PTHIO fueron
determinados en forma secuencial luego de la resección de cada glándula
hipertrófica; 6 de estos 8 pacientes (75%) exhibieron un descenso falso
positivo (descenso mayor de 50% sobre el nivel de base en presencia de otra
glándula hipertrófica) fallando ası́ en la predicción de la presencia de una
segunda glándula hipertrófica. En 2 casos la monitorı́a de PTHIO
constituyó un resultado negativo real, con lo cual se predijo EMG. Si la
EMG se define por macrocriterios morfológicos, la monitorı́a de PTHIO
falla en la predicción confiable de la presencia de EMG. Sin embargo, si la
EMG es definida por criterios funcionales, la evolución de estos pacientes
no parece afectarse en forma significativa. La importancia de estos
hallazgos deber ser investigada más a fondo en relación con el resultado de
los procedimientos de cirugı́a paratiroidea mı́nimamente invasora.
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